These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 20555240)

  • 21. Management of chronic hepatitis B virus infection: current perspectives for the nurse practitioner.
    Perrillo R
    J Am Acad Nurse Pract; 2006 May; 18(5):203-15. PubMed ID: 16681707
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Ribavirin treatment in patients with chronic hepatitis C refractory to interferon-alpha].
    Acero D; Adrados M; González-Huix F; Figa M
    Gastroenterol Hepatol; 1996 May; 19(5):243-6. PubMed ID: 8752565
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis C infection: a review.
    Feng X
    Lippincotts Prim Care Pract; 1999; 3(3):345-53. PubMed ID: 10711135
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Factors of response to treatment with interferon-alpha in patients with chronic hepatitis C. Therapeutic perspectives].
    Marcellin P; Pouteau M; Martinot M; Boyer N; Castelnau C; Benhamou JP; Erlinger S
    Gastroenterol Clin Biol; 1995 Dec; 19(12):991-1000. PubMed ID: 8729410
    [No Abstract]   [Full Text] [Related]  

  • 25. Veterans' healthcare concerns: hepatitis C.
    Polzien G
    Home Healthc Nurse; 2007 May; 25(5):335-8; quiz 339-40. PubMed ID: 17495564
    [No Abstract]   [Full Text] [Related]  

  • 26. [Therapeutic response to alpha-interferon in chronic alcoholics with viral hepatitis C].
    Nikitin IG; Kuznetsov SL; Liuliaeva OD; Storozhakov GI; Kisliakov VA; Uskov IuI
    Klin Med (Mosk); 1998; 76(8):33-5. PubMed ID: 9770965
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Hepatitis C: natural history, biology, treatment monitoring].
    Poynard T
    Pathol Biol (Paris); 1999 Nov; 47(9):911-6. PubMed ID: 10609271
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Newly acquired hepatitis C--many hurdles from diagnosis until treatment initiation.
    Wiegand J
    J Gastroenterol Hepatol; 2008 Dec; 23(12):1782-4. PubMed ID: 19120870
    [No Abstract]   [Full Text] [Related]  

  • 29. [Hepatitis C virus genotype 4: epidemiology and treatment].
    Castera L; Morice Y; Grando V; Bon C; Dény P; Roulot D
    Gastroenterol Clin Biol; 2003 Jun; 27(6-7):596-604. PubMed ID: 12910223
    [No Abstract]   [Full Text] [Related]  

  • 30. Consensus statement to Schering-Plough Pharmaceuticals from the health care community regarding Rebetron development and marketing.
    Notes Undergr; 1999; (No 39):9-13. PubMed ID: 11366786
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clearance of hepatitis C viral RNA in cirrhotic patients with antiviral therapy.
    Ono SK; da Silva LC; Carrilho FJ; da Fonseca LE; Mendes LC; Madruga CL; Farias Ade Q; Laudanna AA
    Rev Hosp Clin Fac Med Sao Paulo; 1996; 51(5):180-3. PubMed ID: 9216095
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The epidemiology and control of hepatitis C infection.
    Gungabissoon U
    Nurs Times; 2003 Aug 5-11; 99(31):24-5. PubMed ID: 13677115
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prospective multicenter study of eligibility for antiviral therapy among 4,084 U.S. veterans with chronic hepatitis C virus infection.
    Bini EJ; Bräu N; Currie S; Shen H; Anand BS; Hu KQ; Jeffers L; Ho SB; Johnson D; Schmidt WN; King P; Cheung R; Morgan TR; Awad J; Pedrosa M; Chang KM; Aytaman A; Simon F; Hagedorn C; Moseley R; Ahmad J; Mendenhall C; Waters B; Strader D; Sasaki AW; Rossi S; Wright TL
    Am J Gastroenterol; 2005 Aug; 100(8):1772-9. PubMed ID: 16086714
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical guidelines of diagnosis and treatment of hepatitis C].
    Rev Gastroenterol Mex; 2007; 72(2):177-91. PubMed ID: 17966381
    [No Abstract]   [Full Text] [Related]  

  • 35. Interferon alpha therapy for hepatitis C: treatment completion and response rates among patients with substance use disorders.
    Huckans MS; Loftis JM; Blackwell AD; Linke A; Hauser P
    Subst Abuse Treat Prev Policy; 2007 Jan; 2():4. PubMed ID: 17222348
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cost-effectiveness analysis of the treatment of chronic hepatitis C].
    Joliot E; Vanlemmens C; Kerleau M; Le Gales C; Woronoff-Lemsi MC; Flori YA; Seror V; Hrusovsky S; Monnet E; Bresson-Hadni S; Miguet JP
    Gastroenterol Clin Biol; 1996; 20(11):958-67. PubMed ID: 9119185
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current challenges in hepatitis C.
    Swan T
    Res Initiat Treat Action; 2004; 10(2):17-20. PubMed ID: 15828096
    [No Abstract]   [Full Text] [Related]  

  • 38. Managing the patient with hypertriglyceridemia: a practical approach for nurse practitioners.
    Rankin FM; Cohen JD
    J Am Acad Nurse Pract; 2008 Dec; 20 Suppl 2():1-14; quiz 15. PubMed ID: 19143900
    [No Abstract]   [Full Text] [Related]  

  • 39. Hepatitis C: be positively aware of the risk of transmission and treatment.
    Johnson B
    Posit Aware; 2002; 13(6):29-31. PubMed ID: 12484333
    [No Abstract]   [Full Text] [Related]  

  • 40. Childhood obesity: prevention practices of nurse practitioners.
    Larsen L; Mandleco B; Williams M; Tiedeman M
    J Am Acad Nurse Pract; 2006 Feb; 18(2):70-9. PubMed ID: 16460413
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.